Cartesian Therapeutics Inc (NAS:RNAC)
$ 7.88 -0.020 (-0.25%) Market Cap: 231.53 Mil Enterprise Value: 124.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 25/100

Cartesian Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 12, 2026 / 02:00PM GMT
Release Date Price: $9.51 (+17.99%)
Carsten Brunn
Cartesian Therapeutics Inc - Chairman of the Board, President, Chief Executive Officer

Good morning. I'm Carsten Brunn, CEO and Chairman of the Board of Cartesian Therapeutics. I'd like to welcome you to our 2026 Annual Meeting of Stockholders and thank you for your ongoing support of Cartesian. I'd let the Chairman of this meeting and Matt Bartholomae, our General Counsel, who let the Secretary.

I'd like to first introduce the other members of our Board of Directors. From the Board are Tim Barabe, Adrian Bot, Nishan de Silva, Kemal Malik, Michael Singer, Tim Springer, and Pat Zenner, our Lead Independent Director.

I'd also like to introduce Fred Williamson and Coleman Pope of Ernst & Young, the company's independent registered public accounting firm, who are available to respond to appropriate questions or ask a question box found on the web portal.

The meeting will now officially come to order. I will now conduct the formal business of the meeting as set forth on the company's notice of annual meeting and proxy statement. We'll now review a few formalities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot